MEK162 for Patients With RAS/RAF/MEK Activated Tumors

ABSTRACT: The purpose of this signal seeking study is to determine whether treatment with MEK162 demonstrates sufficient efficacy in select pathway-activated solid tumors and/or hematologic malignancies to warrant further study

DISEASE(S): Hematologic Neoplasms,Solid Tumor And Hematologic Malignancies

PROVIDER: 2147225 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR